T2S Group Holding Secures Casablanca Stock Exchange Approval for Major 2026 IPO

T2S Group Holding has secured approval from Morocco's Capital Market Authority to list on the Casablanca Stock Exchange, kicking off the 2026 IPO season. The transaction blends a fresh capital increase of roughly 350 million dirhams with the sale of existing shares worth about 750 million dirhams, targeting a maximum raise of MDH 1.099 billion. Founded in 1992 as Technique Science Santé, T2S has grown into a leading medical‑technology group in Morocco and is expanding across French‑speaking sub‑Saharan Africa. The company forecasts strong revenue and profit growth through 2030, backed by new production capacity, a broad African footprint, and a robust pipeline of diagnostic and radiopharmacy projects.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.